SC-404

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameSC-404
Drug Alias NameSC404
ClassificationOther
Mechanisms of ActionLipid modulators
TargetsLipid
Therapy Area/IndicationsCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSancilio & Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSancilio & Company Inc
Active IndicationsN/A
Inactive IndicationsCholangitis, Sclerosing

Other Information

ATC CodeN/A
Related LinksN/A